MedTrace Logo

Long-Term Outcomes After ICU-Treated COVID-19 ARDS

NCT07397156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 283

Last updated 2026-02-09

No results posted yet for this study

Summary

This observational cohort study describes long-term survival and patient-reported health after intensive care unit (ICU) treatment for COVID-19-related acute respiratory distress syndrome (ARDS) in adults treated in a single center in Poland. The main questions it aims to answer are:

1. What is all-cause mortality up to 4 years after ICU admission for COVID-19-related ARDS?
2. Among long-term survivors, what are the health-related quality of life and functional outcomes approximately 4 years after ICU admission?
3. What rehabilitation use, return-to-work outcomes, and self-reported financial burden are reported during follow-up, and which acute-phase clinical and laboratory factors are associated with late mortality and long-term outcomes?

Participants did not receive any experimental intervention as part of this study. The study team collected clinical information from hospital and ICU records and conducted a structured telephone follow-up with survivors using standardized questionnaires (including EQ-5D-5L for quality of life, the modified Medical Research Council \[mMRC\] scale for breathlessness, and the Post-COVID-19 Functional Status \[PCFS\] scale for functional status), as well as questions about rehabilitation and work status.

Conditions

  • COVID-19
  • ARDS (Acute Respiratory Distress Syndrome)

Sponsors & Collaborators

  • University in Zielona Góra

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-08-01
Completion
2025-08-13

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07397156 on ClinicalTrials.gov